Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Cerilliant
QuintilesIMS
Deloitte
Cipla
Argus Health
AstraZeneca
Chinese Patent Office

Generated: October 16, 2018

DrugPatentWatch Database Preview

Iroko Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for IROKO PHARMS LLC, and when can generic versions of IROKO PHARMS LLC drugs launch?

IROKO PHARMS LLC has four approved drugs.

There are thirteen US patents protecting IROKO PHARMS LLC drugs.

Summary for Iroko Pharms Llc
US Patents:13
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Iroko Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 8,999,387 ➤ Try a Free Trial ➤ Try a Free Trial
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 9,186,328 ➤ Try a Free Trial ➤ Try a Free Trial
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 9,180,096 ➤ Try a Free Trial Y ➤ Try a Free Trial
Iroko Pharms Llc TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 RX Yes No 8,992,982 ➤ Try a Free Trial Y ➤ Try a Free Trial
Iroko Pharms Llc INDOCIN indomethacin CAPSULE;ORAL 016059-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Iroko Pharms Llc TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 RX Yes No 8,734,847 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for IROKO PHARMS LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 5 mg and 10 mg ➤ Subscribe 2017-01-09
➤ Subscribe Capsules 18 mg and 35 mg ➤ Subscribe 2014-06-06

International Patents for Iroko Pharms Llc Drugs

Country Document Number Estimated Expiration
Israel 215872 ➤ Try a Free Trial
Japan 6239709 ➤ Try a Free Trial
Canada 2951383 ➤ Try a Free Trial
Uruguay 36172 ➤ Try a Free Trial
South Korea 20120101285 ➤ Try a Free Trial
South Korea 20150018647 ➤ Try a Free Trial
Singapore 175314 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Julphar
Covington
Medtronic
Citi
Teva
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.